Stay updated with breaking news from Diffuse Largeb Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has passed a major milestone for its Azer-cel cell therapy treatment with the dosing of the first patient for its Phase 1b...
The Food and Drug Administration will speed up the review of odronextamab for patients with relasped or refractory follicular lymphoma or diffuse large B-cell lymphoma.
Getting diagnosed with cancer is a scary experience. This mom shares the time her husband was diagnosed with cancer, and how it affected her family.
Expert panelists open their discussion on diffuse large B-cell lymphoma by reflecting on diagnostic strategies and the frontline treatment armamentarium.
Florida Cancer Specialists recently released a case study that outlined its role in the evolution of a first-line therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) that recently received FDA approval.